Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Nanomedicine. 2018 Apr 14;14(4):1381–1394. doi: 10.1016/j.nano.2018.04.008

Figure 8.

Figure 8

A. Mouse tumor tissue sections stained with hematoxylin and eosin (H&E) stain after necropsy reveal significant tumor burden. B. GFP fluorescence reveals tumor cell location. C. RITC fluorescence reveals highly specific nanoparticle tumor targeting; MSN-HA nanoparticles are only localized in tumor cells and not in control intestine. D. MSN-HA co-localizes with CD44 on the membrane of tumor.